Signal2026-07-30
ClinicalTrials.gov

[PHASE1] A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture